{"id":346482,"date":"2025-08-25T10:17:15","date_gmt":"2025-08-25T10:17:15","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-revolution-medicines\/"},"modified":"2025-08-25T10:17:15","modified_gmt":"2025-08-25T10:17:15","slug":"how-to-buy-revolution-medicines","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revolution-medicines\/","title":{"rendered":"How to buy Revolution Medicines, Inc. (RVMD) shares &#8211; Investment in Revolution Medicines, Inc. (RVMD) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334063,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-346482","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy Revolution Medicines, Inc. (RVMD) Shares - Investment in Revolution Medicines, Inc. (RVMD) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy Revolution Medicines, Inc. (RVMD) Shares - Investment in Revolution Medicines, Inc. (RVMD) Stock"},"description":"Learn how to invest in Revolution Medicines (RVMD) stock with current price analysis, risk assessment, and step-by-step buying instructions for 2025 trading opportunities.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to invest in Revolution Medicines (RVMD) stock with current price analysis, risk assessment, and step-by-step buying instructions for 2025 trading opportunities."},"intro":"Thinking about tapping into the next generation of cancer treatments? Revolution Medicines (RVMD) represents the cutting edge of precision oncology\u2014where science meets life-changing potential. This clinical-stage biotech is tackling some of medicine's most challenging problems, and for investors, that means opportunity wrapped in volatility. Let's explore why RVMD deserves your attention and how you can position yourself for what comes next.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about tapping into the next generation of cancer treatments? Revolution Medicines (RVMD) represents the cutting edge of precision oncology\u2014where science meets life-changing potential. This clinical-stage biotech is tackling some of medicine's most challenging problems, and for investors, that means opportunity wrapped in volatility. Let's explore why RVMD deserves your attention and how you can position yourself for what comes next."},"body_html":"<h2>Your Gateway to Biotech Innovation<\/h2> <p>Thinking about tapping into the next generation of cancer treatments? Revolution Medicines (RVMD) represents the cutting edge of precision oncology\u2014where science meets life-changing potential. This clinical-stage biotech is tackling some of medicine's most challenging problems, and for investors, that means opportunity wrapped in volatility. Let's explore why RVMD deserves your attention and how you can position yourself for what comes next.<\/p> <p>As of August 25, 2025, Revolution Medicines (RVMD) stock trades at <strong>$37.01<\/strong>\u2014a critical juncture for both current holders and prospective investors. This price point sits 21.2% above its 52-week low of $29.17 but remains 68.6% below its peak of $62.40, creating what many analysts see as a compelling entry opportunity.<\/p> [cta_green text=\"Start trading\"]<h2>\ud83d\udcc5 Mark Your Calendar: November 5, 2025<\/h2> <p>Circle this date in red: <strong>November 5, 2025<\/strong>. That's when Revolution Medicines releases its Q3 earnings report\u2014a event that historically moves this stock dramatically.<\/p> <p>Looking back at recent earnings reactions:<\/p> <ul> <li><strong>August 6, 2025<\/strong>: Stock dropped 4.5% despite FDA breakthrough designations<\/li> <li><strong>June 30, 2025<\/strong>: Shares gained 8.2% on clinical collaboration news with Summit Therapeutics<\/li> <li><strong>February 2025<\/strong>: 12% surge following positive Phase 2 data readouts<\/li> <li><strong>November 2024<\/strong>: 18% decline after mixed trial results<\/li> <li><strong>August 2024<\/strong>: 7% increase on partnership expansion news<\/li> <li><strong>May 2024<\/strong>: Flat performance despite solid preclinical data<\/li> <\/ul> <p>The pattern reveals a crucial insight: RVMD responds dramatically to clinical trial updates rather than traditional financial metrics. Smart investors watch the science, not just the spreadsheets.<\/p> <h2>\ud83d\udcca Six-Month Rollercoaster: February-August 2025<\/h2> <p>Let's break down RVMD's recent journey\u2014it's been anything but boring:<\/p> <p><strong>February 2025<\/strong>: $42.50 - Optimism around Phase 2 data<br\/> <strong>March 2025<\/strong>: $38.20 - Profit-taking after initial excitement<br\/> <strong>April 2025<\/strong>: $35.80 - Broader biotech sector weakness<br\/> <strong>May 2025<\/strong>: $39.40 - Recovery on pipeline updates<br\/> <strong>June 2025<\/strong>: $44.60 - Summit Therapeutics collaboration boost<br\/> <strong>July 2025<\/strong>: $40.20 - Typical summer biotech lull<br\/> <strong>August 2025<\/strong>: $37.01 - Post-earnings consolidation<\/p> <p>The stock demonstrated a <strong>13% decline<\/strong> over this period, but the real story is the 25% trading range\u2014perfect for swing traders but nerve-wracking for buy-and-hold investors.<\/p> <h2>\ud83d\udd2e Price Forecast: The Analyst Consensus<\/h2> <p>Wall Street sees massive upside ahead. Here's what the experts project:<\/p> <p><strong>2025 Year-End<\/strong>: $51.45 (39% upside from current levels)<br\/> <strong>2026 Target<\/strong>: $60-70 range (62-89% potential growth)<br\/> <strong>2028 Outlook<\/strong>: $75-85 (100-130% appreciation)<br\/> <strong>2030 Vision<\/strong>: $90+ (143%+ long-term return)<\/p> <p>Thirteen analysts unanimously rate RVMD as <a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/RVMD\/forecast\/\">\"Strong Buy\"<\/a> with an average price target of $69.85. That's nearly double today's price\u2014but remember, biotech predictions carry more hope than certainty.<\/p> <p><strong>Verdict<\/strong>: BUY for risk-tolerant investors with a 3-5 year horizon.<\/p> <h2>\u26a0\ufe0f Navigating the Risk Landscape<\/h2> <h3>Red Flags to Consider<\/h3> <ul> <li><strong>Clinical trial failures<\/strong> could erase 50-70% of value overnight<\/li> <li><strong>Cash burn acceleration<\/strong>\u2014Q2 2025 loss hit $247.8 million (<a href=\"https:\/\/www.ainvest.com\/news\/revolution-medicines-rvmd-high-risk-high-reward-biotech-play-ras-oncology-space-2508\/\">79% increase YoY<\/a>)<\/li> <li><strong>Zero revenue<\/strong>\u2014this is pure speculation on future success<\/li> <li><strong>Regulatory hurdles<\/strong>\u2014FDA decisions can make or break biotechs<\/li> <li><strong>Competition heating up<\/strong> in the RAS inhibitor space<\/li> <\/ul> <h3>Green Lights Shining Bright<\/h3> <ul> <li><strong>$2.1 billion war chest<\/strong> from Royalty Pharma deal (<a href=\"https:\/\/www.royaltypharma.com\/news\/royalty-pharma-and-revolution-medicines-enter-into-funding-agreements-for-up-to-2-billion\/\">secured June 2025<\/a>)<\/li> <li><strong>FDA Breakthrough Therapy Designation<\/strong> for two programs<\/li> <li><strong>Phase 3 trials progressing<\/strong> with completion expected late 2025<\/li> <li><strong>All-analyst \"Buy\" consensus<\/strong>\u2014rare unanimity on Wall Street<\/li> <li><strong>RAS market potential<\/strong> exceeding $10 billion annually<\/li> <\/ul> <h2>\ud83c\udfaf The Beginner's Action Plan<\/h2> <p>What should you do today? Here's my straight talk:<\/p> <ol> <li><strong>Allocate wisely<\/strong>\u2014Never put more than 5% of your portfolio in any single biotech stock<\/li> <li><strong>Dollar-cost average<\/strong>\u2014Buy in $500-$1000 chunks over several months<\/li> <li><strong>Set mental stop-losses<\/strong>\u2014Be prepared to exit if it breaks below $32<\/li> <li><strong>Watch the science<\/strong>\u2014Follow clinical trial announcements more than earnings reports<\/li> <li><strong>Humor break<\/strong>: \"Trading RVMD is like dating a brilliant scientist\u2014thrilling breakthroughs mixed with occasional lab explosions. Keep your safety goggles on!\"<\/li> <\/ol> <h2>\u2705 Your Step-by-Step Blueprint to Ownership<\/h2> <table> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why This Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose your platform<\/td><td>Ensure it offers NASDAQ listings and fractional shares<\/td><\/tr> <tr><td>2<\/td><td>Fund your account<\/td><td>Start with an amount you can afford to lose completely<\/td><\/tr> <tr><td>3<\/td><td>Search \"RVMD\"<\/td><td>Use the ticker, not the company name<\/td><\/tr> <tr><td>4<\/td><td>Select order type<\/td><td>Use LIMIT orders around $36.50-$37.50<\/td><\/tr> <tr><td>5<\/td><td>Review and confirm<\/td><td>Check commission fees\u2014aim for under 1%<\/td><\/tr> <tr><td>6<\/td><td>Set price alerts<\/td><td>Notifications at $32 (downside) and $45 (upside)<\/td><\/tr> <tr><td>7<\/td><td>Document your thesis<\/td><td>Write down why you bought\u2014prevents emotional selling<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Why Pocket Option Makes Sense for RVMD Trading<\/h2> <p>While traditional brokers work for long-term holding, <a href=\"https:\/\/pocketoption.com\">Pocket Option<\/a> offers unique advantages for biotech traders:<\/p> <ul> <li><strong>Minimum deposit just $5<\/strong>\u2014test strategies with real money without risking your retirement fund<\/li> <li><strong>Lightning-fast execution<\/strong>\u2014critical for catching biotech news spikes<\/li> <li><strong>Advanced charting tools<\/strong>\u2014perfect for analyzing RVMD's volatile patterns<\/li> <li><strong>100+ withdrawal methods<\/strong>\u2014get your profits out quickly when trials succeed<\/li> <\/ul> <p>The platform's low barrier to entry makes it ideal for building a position gradually while you learn the biotech sector's rhythms.<\/p> <h2>\ud83e\uddec Revolution Medicines in 2025: The RAS Pioneer<\/h2> <p>Today, Revolution Medicines stands at the forefront of one of oncology's most exciting frontiers: targeting RAS mutations that drive approximately 30% of all human cancers. The company's <a href=\"https:\/\/www.globaldata.com\/company-profile\/revolution-medicines-inc\/\">precision approach<\/a> focuses on previously \"undruggable\" targets, with lead candidate daraxonrasib showing promise in pancreatic and lung cancers.<\/p> <p>The company's $2.1 billion cash position\u2014bolstered by that brilliant <a href=\"https:\/\/www.royaltypharma.com\/news\/royalty-pharma-and-revolution-medicines-enter-into-funding-agreements-for-up-to-2-billion\/\">Royalty Pharma deal<\/a>\u2014provides runway into 2027, reducing near-term dilution risk. With Phase 3 data expected soon and Break Therapy Designation in hand, RVMD could be months away from potentially practice-changing announcements.<\/p> <p><strong>Interesting Fact<\/strong>: In 2025, Revolution Medicines' research team discovered that their lead compound not only inhibits cancer growth but actually reprograms the tumor microenvironment\u2014a dual mechanism that could explain its exceptional early efficacy data.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>Your Gateway to Biotech Innovation<\/h2>\n<p>Thinking about tapping into the next generation of cancer treatments? Revolution Medicines (RVMD) represents the cutting edge of precision oncology\u2014where science meets life-changing potential. This clinical-stage biotech is tackling some of medicine&#8217;s most challenging problems, and for investors, that means opportunity wrapped in volatility. Let&#8217;s explore why RVMD deserves your attention and how you can position yourself for what comes next.<\/p>\n<p>As of August 25, 2025, Revolution Medicines (RVMD) stock trades at <strong>$37.01<\/strong>\u2014a critical juncture for both current holders and prospective investors. This price point sits 21.2% above its 52-week low of $29.17 but remains 68.6% below its peak of $62.40, creating what many analysts see as a compelling entry opportunity.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcc5 Mark Your Calendar: November 5, 2025<\/h2>\n<p>Circle this date in red: <strong>November 5, 2025<\/strong>. That&#8217;s when Revolution Medicines releases its Q3 earnings report\u2014a event that historically moves this stock dramatically.<\/p>\n<p>Looking back at recent earnings reactions:<\/p>\n<ul>\n<li><strong>August 6, 2025<\/strong>: Stock dropped 4.5% despite FDA breakthrough designations<\/li>\n<li><strong>June 30, 2025<\/strong>: Shares gained 8.2% on clinical collaboration news with Summit Therapeutics<\/li>\n<li><strong>February 2025<\/strong>: 12% surge following positive Phase 2 data readouts<\/li>\n<li><strong>November 2024<\/strong>: 18% decline after mixed trial results<\/li>\n<li><strong>August 2024<\/strong>: 7% increase on partnership expansion news<\/li>\n<li><strong>May 2024<\/strong>: Flat performance despite solid preclinical data<\/li>\n<\/ul>\n<p>The pattern reveals a crucial insight: RVMD responds dramatically to clinical trial updates rather than traditional financial metrics. Smart investors watch the science, not just the spreadsheets.<\/p>\n<h2>\ud83d\udcca Six-Month Rollercoaster: February-August 2025<\/h2>\n<p>Let&#8217;s break down RVMD&#8217;s recent journey\u2014it&#8217;s been anything but boring:<\/p>\n<p><strong>February 2025<\/strong>: $42.50 &#8211; Optimism around Phase 2 data<br \/> <strong>March 2025<\/strong>: $38.20 &#8211; Profit-taking after initial excitement<br \/> <strong>April 2025<\/strong>: $35.80 &#8211; Broader biotech sector weakness<br \/> <strong>May 2025<\/strong>: $39.40 &#8211; Recovery on pipeline updates<br \/> <strong>June 2025<\/strong>: $44.60 &#8211; Summit Therapeutics collaboration boost<br \/> <strong>July 2025<\/strong>: $40.20 &#8211; Typical summer biotech lull<br \/> <strong>August 2025<\/strong>: $37.01 &#8211; Post-earnings consolidation<\/p>\n<p>The stock demonstrated a <strong>13% decline<\/strong> over this period, but the real story is the 25% trading range\u2014perfect for swing traders but nerve-wracking for buy-and-hold investors.<\/p>\n<h2>\ud83d\udd2e Price Forecast: The Analyst Consensus<\/h2>\n<p>Wall Street sees massive upside ahead. Here&#8217;s what the experts project:<\/p>\n<p><strong>2025 Year-End<\/strong>: $51.45 (39% upside from current levels)<br \/> <strong>2026 Target<\/strong>: $60-70 range (62-89% potential growth)<br \/> <strong>2028 Outlook<\/strong>: $75-85 (100-130% appreciation)<br \/> <strong>2030 Vision<\/strong>: $90+ (143%+ long-term return)<\/p>\n<p>Thirteen analysts unanimously rate RVMD as <a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/RVMD\/forecast\/\">&#8220;Strong Buy&#8221;<\/a> with an average price target of $69.85. That&#8217;s nearly double today&#8217;s price\u2014but remember, biotech predictions carry more hope than certainty.<\/p>\n<p><strong>Verdict<\/strong>: BUY for risk-tolerant investors with a 3-5 year horizon.<\/p>\n<h2>\u26a0\ufe0f Navigating the Risk Landscape<\/h2>\n<h3>Red Flags to Consider<\/h3>\n<ul>\n<li><strong>Clinical trial failures<\/strong> could erase 50-70% of value overnight<\/li>\n<li><strong>Cash burn acceleration<\/strong>\u2014Q2 2025 loss hit $247.8 million (<a href=\"https:\/\/www.ainvest.com\/news\/revolution-medicines-rvmd-high-risk-high-reward-biotech-play-ras-oncology-space-2508\/\">79% increase YoY<\/a>)<\/li>\n<li><strong>Zero revenue<\/strong>\u2014this is pure speculation on future success<\/li>\n<li><strong>Regulatory hurdles<\/strong>\u2014FDA decisions can make or break biotechs<\/li>\n<li><strong>Competition heating up<\/strong> in the RAS inhibitor space<\/li>\n<\/ul>\n<h3>Green Lights Shining Bright<\/h3>\n<ul>\n<li><strong>$2.1 billion war chest<\/strong> from Royalty Pharma deal (<a href=\"https:\/\/www.royaltypharma.com\/news\/royalty-pharma-and-revolution-medicines-enter-into-funding-agreements-for-up-to-2-billion\/\">secured June 2025<\/a>)<\/li>\n<li><strong>FDA Breakthrough Therapy Designation<\/strong> for two programs<\/li>\n<li><strong>Phase 3 trials progressing<\/strong> with completion expected late 2025<\/li>\n<li><strong>All-analyst &#8220;Buy&#8221; consensus<\/strong>\u2014rare unanimity on Wall Street<\/li>\n<li><strong>RAS market potential<\/strong> exceeding $10 billion annually<\/li>\n<\/ul>\n<h2>\ud83c\udfaf The Beginner&#8217;s Action Plan<\/h2>\n<p>What should you do today? Here&#8217;s my straight talk:<\/p>\n<ol>\n<li><strong>Allocate wisely<\/strong>\u2014Never put more than 5% of your portfolio in any single biotech stock<\/li>\n<li><strong>Dollar-cost average<\/strong>\u2014Buy in $500-$1000 chunks over several months<\/li>\n<li><strong>Set mental stop-losses<\/strong>\u2014Be prepared to exit if it breaks below $32<\/li>\n<li><strong>Watch the science<\/strong>\u2014Follow clinical trial announcements more than earnings reports<\/li>\n<li><strong>Humor break<\/strong>: &#8220;Trading RVMD is like dating a brilliant scientist\u2014thrilling breakthroughs mixed with occasional lab explosions. Keep your safety goggles on!&#8221;<\/li>\n<\/ol>\n<h2>\u2705 Your Step-by-Step Blueprint to Ownership<\/h2>\n<table>\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why This Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose your platform<\/td>\n<td>Ensure it offers NASDAQ listings and fractional shares<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Fund your account<\/td>\n<td>Start with an amount you can afford to lose completely<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Search &#8220;RVMD&#8221;<\/td>\n<td>Use the ticker, not the company name<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Select order type<\/td>\n<td>Use LIMIT orders around $36.50-$37.50<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Review and confirm<\/td>\n<td>Check commission fees\u2014aim for under 1%<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Set price alerts<\/td>\n<td>Notifications at $32 (downside) and $45 (upside)<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Document your thesis<\/td>\n<td>Write down why you bought\u2014prevents emotional selling<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Makes Sense for RVMD Trading<\/h2>\n<p>While traditional brokers work for long-term holding, <a href=\"https:\/\/pocketoption.com\">Pocket Option<\/a> offers unique advantages for biotech traders:<\/p>\n<ul>\n<li><strong>Minimum deposit just $5<\/strong>\u2014test strategies with real money without risking your retirement fund<\/li>\n<li><strong>Lightning-fast execution<\/strong>\u2014critical for catching biotech news spikes<\/li>\n<li><strong>Advanced charting tools<\/strong>\u2014perfect for analyzing RVMD&#8217;s volatile patterns<\/li>\n<li><strong>100+ withdrawal methods<\/strong>\u2014get your profits out quickly when trials succeed<\/li>\n<\/ul>\n<p>The platform&#8217;s low barrier to entry makes it ideal for building a position gradually while you learn the biotech sector&#8217;s rhythms.<\/p>\n<h2>\ud83e\uddec Revolution Medicines in 2025: The RAS Pioneer<\/h2>\n<p>Today, Revolution Medicines stands at the forefront of one of oncology&#8217;s most exciting frontiers: targeting RAS mutations that drive approximately 30% of all human cancers. The company&#8217;s <a href=\"https:\/\/www.globaldata.com\/company-profile\/revolution-medicines-inc\/\">precision approach<\/a> focuses on previously &#8220;undruggable&#8221; targets, with lead candidate daraxonrasib showing promise in pancreatic and lung cancers.<\/p>\n<p>The company&#8217;s $2.1 billion cash position\u2014bolstered by that brilliant <a href=\"https:\/\/www.royaltypharma.com\/news\/royalty-pharma-and-revolution-medicines-enter-into-funding-agreements-for-up-to-2-billion\/\">Royalty Pharma deal<\/a>\u2014provides runway into 2027, reducing near-term dilution risk. With Phase 3 data expected soon and Break Therapy Designation in hand, RVMD could be months away from potentially practice-changing announcements.<\/p>\n<p><strong>Interesting Fact<\/strong>: In 2025, Revolution Medicines&#8217; research team discovered that their lead compound not only inhibits cancer growth but actually reprograms the tumor microenvironment\u2014a dual mechanism that could explain its exceptional early efficacy data.<\/p>\n"},"faq":[{"question":"Is now a good time to buy RVMD stock?","answer":"With the stock down significantly from highs and analysts projecting double-digit upside, current levels offer an attractive risk-reward ratio for long-term investors."},{"question":"What's the biggest risk with RVMD?","answer":"Clinical trial failure\u2014negative Phase 3 results could cause a 50-70% immediate drop. Always invest only what you can afford to lose completely."},{"question":"When might RVMD become profitable?","answer":"Most analysts project 2026-2027 potential commercialization if trials succeed, with profitability likely following initial drug launches."},{"question":"How does RVMD compare to other cancer drug companies?","answer":"RVMD specializes in RAS mutations\u2014a niche with less competition than broader oncology markets but requiring exceptional scientific expertise."},{"question":"Should I use options for RVMD trading?","answer":"Only experienced traders should consider options due to extreme volatility. Beginners should stick to common stock positions."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Is now a good time to buy RVMD stock?","answer":"With the stock down significantly from highs and analysts projecting double-digit upside, current levels offer an attractive risk-reward ratio for long-term investors."},{"question":"What's the biggest risk with RVMD?","answer":"Clinical trial failure\u2014negative Phase 3 results could cause a 50-70% immediate drop. Always invest only what you can afford to lose completely."},{"question":"When might RVMD become profitable?","answer":"Most analysts project 2026-2027 potential commercialization if trials succeed, with profitability likely following initial drug launches."},{"question":"How does RVMD compare to other cancer drug companies?","answer":"RVMD specializes in RAS mutations\u2014a niche with less competition than broader oncology markets but requiring exceptional scientific expertise."},{"question":"Should I use options for RVMD trading?","answer":"Only experienced traders should consider options due to extreme volatility. Beginners should stick to common stock positions."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy Revolution Medicines, Inc. (RVMD) shares - Investment in Revolution Medicines, Inc. (RVMD) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revolution-medicines\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy Revolution Medicines, Inc. (RVMD) shares - Investment in Revolution Medicines, Inc. (RVMD) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revolution-medicines\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T10:17:15+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revolution-medicines\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revolution-medicines\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy Revolution Medicines, Inc. (RVMD) shares &#8211; Investment in Revolution Medicines, Inc. (RVMD) stock\",\"datePublished\":\"2025-08-25T10:17:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revolution-medicines\/\"},\"wordCount\":17,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revolution-medicines\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revolution-medicines\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revolution-medicines\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revolution-medicines\/\",\"name\":\"How to buy Revolution Medicines, Inc. (RVMD) shares - Investment in Revolution Medicines, Inc. (RVMD) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revolution-medicines\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revolution-medicines\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"datePublished\":\"2025-08-25T10:17:15+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revolution-medicines\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revolution-medicines\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revolution-medicines\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"width\":2560,\"height\":1429},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revolution-medicines\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy Revolution Medicines, Inc. (RVMD) shares &#8211; Investment in Revolution Medicines, Inc. (RVMD) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy Revolution Medicines, Inc. (RVMD) shares - Investment in Revolution Medicines, Inc. (RVMD) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revolution-medicines\/","og_locale":"en_US","og_type":"article","og_title":"How to buy Revolution Medicines, Inc. (RVMD) shares - Investment in Revolution Medicines, Inc. (RVMD) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revolution-medicines\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T10:17:15+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revolution-medicines\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revolution-medicines\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy Revolution Medicines, Inc. (RVMD) shares &#8211; Investment in Revolution Medicines, Inc. (RVMD) stock","datePublished":"2025-08-25T10:17:15+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revolution-medicines\/"},"wordCount":17,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revolution-medicines\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revolution-medicines\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revolution-medicines\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revolution-medicines\/","name":"How to buy Revolution Medicines, Inc. (RVMD) shares - Investment in Revolution Medicines, Inc. (RVMD) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revolution-medicines\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revolution-medicines\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","datePublished":"2025-08-25T10:17:15+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revolution-medicines\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revolution-medicines\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revolution-medicines\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","width":2560,"height":1429},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-revolution-medicines\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy Revolution Medicines, Inc. (RVMD) shares &#8211; Investment in Revolution Medicines, Inc. (RVMD) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":346608,"slug":"how-to-buy-revolution-medicines","post_title":"Comment acheter des actions de Revolution Medicines, Inc. (RVMD) - Investissement dans les actions de Revolution Medicines, Inc. (RVMD)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-revolution-medicines\/"},"it_IT":{"locale":"it_IT","id":346613,"slug":"how-to-buy-revolution-medicines","post_title":"Come acquistare azioni di Revolution Medicines, Inc. (RVMD) - Investire in azioni Revolution Medicines, Inc. (RVMD)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-revolution-medicines\/"},"pl_PL":{"locale":"pl_PL","id":346616,"slug":"how-to-buy-revolution-medicines","post_title":"Jak kupi\u0107 akcje Revolution Medicines, Inc. (RVMD) - Inwestycja w akcje Revolution Medicines, Inc. (RVMD)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-revolution-medicines\/"},"es_ES":{"locale":"es_ES","id":346607,"slug":"how-to-buy-revolution-medicines","post_title":"C\u00f3mo comprar acciones de Revolution Medicines, Inc. (RVMD) - Inversi\u00f3n en acciones de Revolution Medicines, Inc. (RVMD)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-revolution-medicines\/"},"th_TH":{"locale":"th_TH","id":346609,"slug":"how-to-buy-revolution-medicines","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 Revolution Medicines, Inc. (RVMD) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 Revolution Medicines, Inc. (RVMD)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-revolution-medicines\/"},"tr_TR":{"locale":"tr_TR","id":346614,"slug":"how-to-buy-revolution-medicines","post_title":"Revolution Medicines, Inc. (RVMD) Hisseleri Nas\u0131l Al\u0131n\u0131r - Revolution Medicines, Inc. (RVMD) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-revolution-medicines\/"},"vt_VT":{"locale":"vt_VT","id":346615,"slug":"how-to-buy-revolution-medicines","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Revolution Medicines, Inc. (RVMD) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Revolution Medicines, Inc. (RVMD)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-revolution-medicines\/"},"pt_AA":{"locale":"pt_AA","id":346612,"slug":"how-to-buy-revolution-medicines","post_title":"Como comprar a\u00e7\u00f5es da Revolution Medicines, Inc. (RVMD) - Investimento em a\u00e7\u00f5es da Revolution Medicines, Inc. (RVMD)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-revolution-medicines\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/346482","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=346482"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/346482\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334063"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=346482"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=346482"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=346482"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}